The importance of sulfation beyond heparan sulfate in Chlamydia infection. (A) Bar graph comparing the attachment of C. trachomatis L2 of the null clones. A one-sided unpaired t test shows less attachment of chlamydia to SLC35B2GT versus B3GAT3GT, to B3GAT3GT versus B4GALT7GT, and to SLC35B2GT versus B4GALT7GT (P = 0.0418, 0.0232, and 0.0139, respectively). (B) Infectivity of C. trachomatis L2 recovered from WT and null clones (B3GAT3GT, B4GALT7GT, and SLC35B2GT). At 36 h after infection of the clones, Chlamydia was harvested and used to inoculate McCoy cells for tittering. Chlamydia inclusions were detected by immunofluorescence and enumerated by counting inclusions (IFU). n = 3. The differences between B3GAT3GT and SLC35B2GT, between B3GAT3GT and B4GALT7GT, and between B4GALT7GT and SLC35B2GT are significant by the one-sided unpaired t test (P < 0.0001, < 0.0012, and < 0.0002, respectively). (C) FACS histograms of the null clones and WT clone stained with anti-heparan sulfate antibody before and after heparitinase digestion. The B3GAT3 and B4GALT7 clones are completely deficient in heparan sulfate proteins, whereas the SLC35B2 clone has ∼5% of cells positive for heparan sulfate. (D) (Left) Autoradiogram control showing equivalent incorporation of [35S]met/[35S]cys in the null clones and WT clone. (Right) Autoradiogram showing a 90–95% reduction in the incorporation of 35SO4 in the SLC35B2 null clone (SLC35B2GT) compared with the WT clone. The SLC35B2 null clone has less sulfated proteins than the B3GAT3 null clone, which has less sulfated proteins than the B4GALT7 null clone.